Home › Agent Hub › Agent Tools › Part D coverage by drug › Advair
Agent Tools
Advair is a brand of fluticasone / salmeterol. What agents check before quoting it: how many 2027 Part D plans cover it, on which tier, with what restrictions and copays, by plan type, carrier and state.
In 2027, 3,542 of 5,492 Medicare Part D and Medicare Advantage drug plans (64.5%) list Advair on their formulary, across 233 of 286 formularies. The most common placement is tier 3 (3,165 plans, 89.4% of those covering it). 0 of the covering plans require prior authorization (0%), 3 step therapy and 3,417 a quantity limit. Generic fluticasone / salmeterol is on 5,289 of 5,492 plans (96.3%).
486 covering plans charge a flat copay for a 30-day supply at a preferred retail pharmacy after the deductible — median $42, 65 of them $0; 3,056 charge coinsurance instead — median 21% of the drug's cost. Once a member's out-of-pocket drug spending reaches $2,400 in 2027, covered drugs cost $0 for the rest of the year.
2026: 3,661 of 5,496 plans covered it (66.6%); 2027: 3,542 of 5,492 (64.5%).
Of 4,367 plans offered in both years, 6 added it to the formulary and 103 dropped it.
Among plans covering it both years, 57 moved it to a higher tier and 202 to a lower one; 0 added prior authorization and 0 removed it.
| Tier | Plans |
|---|---|
| Tier 1 | 106 |
| Tier 2 | 241 |
| Tier 3 | 3,165 |
| Tier 4 | 30 |
| Plan type | Plans covering | Share | Prior auth |
|---|---|---|---|
| Stand-alone Part D (PDP) | 91 of 323 | 28.2% | 0% |
| Medicare Advantage with drugs (MA-PD) | 2,115 of 3,200 | 66.1% | 0% |
| Special needs plans (SNP) | 1,336 of 1,969 | 67.9% | 0% |
| Carrier | Plans covering | Usual tier | Prior auth |
|---|---|---|---|
| Humana | 744 of 846 | Tier 3 | 0 |
| UnitedHealthcare | 0 of 830 | No tier listed | 0 |
| Devoted Health | 728 of 728 | Tier 3 | 0 |
| Aetna Medicare | 0 of 631 | No tier listed | 0 |
| Wellcare | 234 of 268 | Tier 2 | 0 |
| HealthSpring | 226 of 226 | Tier 3 | 0 |
| Kaiser Permanente | 112 of 112 | Tier 3 | 0 |
| SCAN Health Plan | 83 of 83 | Tier 3 | 0 |
| Highmark Blue Cross Blue Shield or Highmark Blue Shield | 80 of 80 | Tier 3 | 0 |
| Alignment Health Plan | 77 of 77 | Tier 3 | 0 |
| Anthem Blue Cross and Blue Shield | 74 of 74 | Tier 3 | 0 |
| Wellpoint | 63 of 63 | Tier 3 | 0 |
| Priority Health Medicare | 40 of 40 | Tier 3 | 0 |
| CarePlus Health Plans, Inc. | 37 of 37 | Tier 3 | 0 |
| Zing Health | 36 of 36 | Tier 3 | 0 |
| Capital Blue Cross | 8 of 35 | Tier 3 | 0 |
| Prominence Health Plan | 0 of 29 | No tier listed | 0 |
| Medica | 1 of 27 | Tier 3 | 0 |
| Anthem HealthKeepers | 26 of 26 | Tier 3 | 0 |
| Blue Cross Blue Shield of Michigan | 26 of 26 | Tier 3 | 0 |
| State | Plans covering | Share |
|---|---|---|
| Alabama | 83 of 114 | 72.8% |
| Alaska | 2 of 9 | 22.2% |
| American Samoa | 0 of 1 | 0% |
| Arizona | 113 of 147 | 76.9% |
| Arkansas | 54 of 85 | 63.5% |
| California | 324 of 397 | 81.6% |
| Colorado | 66 of 106 | 62.3% |
| Connecticut | 30 of 54 | 55.6% |
| Delaware | 24 of 43 | 55.8% |
| District of Columbia | 5 of 12 | 41.7% |
| Florida | 356 of 545 | 65.3% |
| Georgia | 104 of 149 | 69.8% |
| Guam | 0 of 1 | 0% |
| Hawaii | 38 of 50 | 76% |
| Idaho | 17 of 45 | 37.8% |
| Illinois | 86 of 132 | 65.2% |
| Indiana | 98 of 138 | 71% |
| Iowa | 36 of 64 | 56.3% |
| Kansas | 42 of 84 | 50% |
| Kentucky | 83 of 121 | 68.6% |
| Louisiana | 86 of 125 | 68.8% |
| Maine | 31 of 52 | 59.6% |
| Maryland | 38 of 49 | 77.6% |
| Massachusetts | 38 of 89 | 42.7% |
| Michigan | 152 of 182 | 83.5% |
| Minnesota | 25 of 63 | 39.7% |
| Mississippi | 68 of 104 | 65.4% |
| Missouri | 97 of 170 | 57.1% |
| Montana | 16 of 27 | 59.3% |
| Nebraska | 28 of 51 | 54.9% |
| Nevada | 49 of 100 | 49% |
| New Hampshire | 14 of 25 | 56% |
| New Jersey | 42 of 73 | 57.5% |
| New Mexico | 33 of 68 | 48.5% |
| New York | 118 of 215 | 54.9% |
| North Carolina | 120 of 176 | 68.2% |
| North Dakota | 6 of 26 | 23.1% |
| Northern Mariana Islands | 0 of 1 | 0% |
| Ohio | 95 of 171 | 55.6% |
| Oklahoma | 50 of 81 | 61.7% |
| Oregon | 75 of 92 | 81.5% |
| Pennsylvania | 201 of 323 | 62.2% |
| Puerto Rico | 26 of 64 | 40.6% |
| Rhode Island | 11 of 29 | 37.9% |
| South Carolina | 60 of 89 | 67.4% |
| South Dakota | 6 of 30 | 20% |
| Tennessee | 119 of 156 | 76.3% |
| Texas | 266 of 407 | 65.4% |
| U.S. Virgin Islands | 0 of 1 | 0% |
| Utah | 25 of 53 | 47.2% |
| Vermont | 8 of 14 | 57.1% |
| Virginia | 88 of 144 | 61.1% |
| Washington | 77 of 114 | 67.5% |
| West Virginia | 41 of 69 | 59.4% |
| Wisconsin | 50 of 96 | 52.1% |
| Wyoming | 6 of 13 | 46.2% |
Medicare Part D paid for 1,332,305 30-day fills of Advair in 2024 for about 309,532 enrollees, at an average total cost of $292.58 per 30-day fill (CMS Part D Prescribers by Geography and Drug, national).
Price Advair and the rest of a client's list on every plan in their county.
Free tools for licensed insurance agents. Data from CMS public files; verify with plan documents before advising a client.
Counts are over every Medicare Advantage drug plan and stand-alone Part D plan in the CMS monthly formulary files, excluding employer plans. A plan counts as covering a drug when any strength or form of it is on the plan’s formulary; the tier, prior authorization, step therapy and quantity limit shown are the most favorable version on that formulary. Copays are for a 30-day supply at a preferred retail pharmacy after the deductible. This is a reference for licensed agents, not a plan recommendation; verify with the plan’s formulary before advising a client. Source: CMS Part D formulary files (release 10/08/2026). CMS formulary data.